A 56-year-old man with an implantable cardioverter-defibrillator (ICD) presented with unexplained heart palpitations, which were usually aggravated after ingesting alcohol. He had a history of coronary artery bypass graft surgery 8 years ago, and an ICD was placed (i.e. a single ventricular shock coil with integrated atrial-sensing rings [VDD ICD lead]) 1.5 years ago for primary prevention of sudden cardiac death associated with ischemic cardiomyopathy. Repeated electrocardiograms and echocardiograms showed no evidence of atrial flutter-fibrillation; this was clearly demonstrated using several atrial electrogram strips during the ICD analysis.
1,2 Device-detected AF, even if asymptomatic, has been closely associated with an increased risk for stroke or systemic embolism. 3, 4 In addition, subclinical AF has been detected in almost 30% of patients with cryptogenic stroke when continuously monitored using implantable cardiac devices. 5 We report the case of a patient with subclinical AF detected only after ICD analysis with integrated atrial-sensing rings.
Case
A 56-year-old man presented with several episodes of unexplained heart palpitations, which were usually aggravated one The CHA₂DS₂-VASc (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke/transient ischemic attack
[TIA], vascular disease, age 65-74 years, sex category) score of the patient was calculated and determined to be two, because of the patient's history of diabetes and heart failure; antiarrhythmic and anticoagulation therapies were initiated after confirming the presence of significant atrial flutter-fibrillation.
Discussion
The incidence of device-detected atrial tachyarrhythmia was reported in up to 50% of patients during a 2-year follow-up. [1] [2] [3] [4] [5] [6] However, a significant proportion of those episodes may be silent (approximately 90%), increasing the risk for delayed anticoagulation therapy in patients with a high risk for stroke. 7 Detection of subclinical AF using a conventional singlechamber ICD system is quite limited. In addition, ICD recipients usually have several risk factors for stroke, including congestive heart failure, hypertension, old age, diabetes, and past history of systemic embolism. Using a dual-chamber ICD with an independent atrial lead may enhance the efficacy of AF detection;
however, dual-chamber ICD placement is usually associated with higher costs, longer fluoroscopy and procedure time, and more complications, including pneumothorax, tamponade, hematoma, and lead dislodgement. 8, 9 Moreover, using a dual-chamber ICD could make the subsequent lead extractions more difficult in case of ICD system infection. Detection of Subclinical Atrial Fibrillation with a Novel VDD Implantable Cardioverter-Defibrillator (performed >10 times), transmitral E-and A-waves were always measured by pulsed-wave Doppler. Combined ECG recording during examination also revealed no AF rhythms. In patients with a high risk for stroke (CHA₂DS₂-VASc score, 2), optimal anticoagulation therapy may be greatly delayed if conventional ICD were placed. Therefore, this novel VDD ICD system with two integrated atrial sensing functions may be useful in better managing patients with silent AF, without increasing the complexity of an ICD procedure.
